Zydus receives final approval from the US FDA for Sildenafil for oral suspension

Zydus Lifesciences has received final approval from the US Food and Drug Administration (FDA) to market Sildenafil for oral suspension USP 10 mg/ml, a company statement notified.

Sildenafil for oral suspension is used to treat high blood pressure in the lungs (pulmonary hypertension). It works by relaxing and widening the blood vessels in lungs which allows the blood to flow more easily.

Decreasing high blood pressure in the lungs allows the heart and lungs to work better, and improves the ability to exercise. The drug will be manufactured at the group’s formulation manufacturing facility at Baddi, Himachal Pradesh, said the statement.